|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Transport Pharmaceuticals And Nexus Therapeutics, Inc. Announce Expansion Of The Board And Management Teams Through The Addition Of Key Personnel
10/19/2005 5:13:06 PM
FRAMINGHAM, Mass. & PHILADELPHIA--(BUSINESS WIRE)--March 23, 2005--
-- Tom Amick, Former VP of Business Development for Johnson & Johnson's Investment Arm, Joins Transport's Board of Directors--
Transport Pharmaceuticals, Inc. (Transport) announced today that it has appointed Tom Amick, former vice president of business development at Johnson & Johnson Development Corporation, to the Company's Board of Directors. Transport operates under the management of neXus therapeutics, inc. (neXus), which has strengthened its senior team through the addition of several key hires and promotions within the firms' clinical, regulatory, and commercialization groups.
|
|
|
|
|
|
|
|
|
|
|